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Abstract
Background Sedation and therapeutic hypothermia (TH)
delay neurological responses and might reduce the accu-
racy of clinical examination to predict outcome after
cardiac arrest (CA). We examined the accuracy of quan-
titative pupillary light reactivity (PLR), using an automated
infrared pupillometry, to predict outcome of post-CA coma
in comparison to standard PLR, EEG, and somato-sensory
evoked potentials (SSEP).
Methods We prospectively studied over a 1-year period
(June 2012–June 2013) 50 consecutive comatose CA
patients treated with TH (33 C, 24 h). Quantitative PLR
(expressed as the % of pupillary response to a calibrated
light stimulus) and standard PLR were measured at day 1
(TH and sedation; on average 16 h after CA) and day 2
(normothermia, off sedation: on average 46 h after CA).
Neurological outcome was assessed at 90 days with
Cerebral Performance Categories (CPC), dichotomized as
good (CPC 1–2) versus poor (CPC 3–5). Predictive per-
formance was analyzed using area under the ROC curves
(AUC).
Results Patients with good outcome [n = 23 (46 %)] had
higher quantitative PLR than those with poor outcome
[n = 27; 16 (range 9–23) vs. 10 (1–30) % at day 1, and 20
(13–39) vs. 11 (1–55) % at day 2, both p < 0.001]. Best
cut-off for outcome prediction of quantitative PLR was
<13 %. The AUC to predict poor outcome was higher for
quantitative than for standard PLR at both time points (day
1, 0.79 vs. 0.56, p = 0.005; day 2, 0.81 vs. 0.64,
p = 0.006). Prognostic accuracy of quantitative PLR was
comparable to that of EEG and SSEP (0.81 vs. 0.80 and
0.73, respectively, both p > 0.20).
Conclusions Quantitative PLR is more accurate than
standard PLR in predicting outcome of post-anoxic coma,
irrespective of temperature and sedation, and has compa-
rable prognostic accuracy than EEG and SSEP.
Keywords Cardiac arrest  Therapeutic hypothermia 
Outcome  Coma  Prognosis  Pupillometry 
Pupillary light reactivity  Pupillary response  EEG 
Evoked potentials
Introduction
Implementation of post-resuscitation care and therapeutic
hypothermia (TH) has significantly increased the number of
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patients surviving from prolonged cardiac arrest (CA) with a
good neurological recovery [1, 2]. TH and comprehensive
post-resuscitation care is expensive and resource intensive.
Patients who will have good recovery are currently often
indistinguishable from patients who will eventually have a
poor prognosis. In this context, adequate prognostication of
neurological outcome in the early phase following CA is of
great importance, particularly because it may allow appro-
priate allocation of resources [3]. The initial assessment of
prognosis in post-CA comatose patients is primarily based
on neurological examination [4]. However, sedation and
hypothermia delay drug elimination and alter clinical tests
[5, 6]. In the setting of TH, standard neurological exami-
nation (including motor response and brainstem reflexes)
may not always be accurate to predict neurological recovery
[7–9]. The addition of electroencephalography (EEG) [9–
12] and somato-sensory evoked potentials (SSEP) [13, 14]
might significantly improve prognostication of post-CA
coma. However, EEG and SSEP are not always available
and require specific expertise for their interpretation [15]. In
this setting, the ideal tool would be a simple, widely avail-
able, and quantitative technique.
Automated video pupillometry is a novel electronic device
that contains an infrared light camera which enables to
measure quantitatively the percentage of pupillary reaction to
a calibrated light stimulation. In critically ill patients, two
preliminary studies found that the measurement of pupillary
size with an automated pupillometer was more accurate than
standard pupillary examination using a manual pen light [16,
17]. Yan et al. [18], in a larger cohort of liver transplant
patients, found that peri-operative pupillary abnormalities
measured with quantitative pupillometry were associated
with neurological complications. Behrends et al. [19], in a
small cohort of 30 patients, found that quantitative pupillary
reactivity performed during cardio-pulmonary resuscitation
was associated with early survival. No studies have examined
the potential value of automated pupillometry in predicting
neurological outcome of comatose critically ill patients in
general and of comatose post-CA patients in particular. The
objective of this prospective observational double-blinded
study was to evaluate whether automated quantitative pupil-
lometry had higher accuracy than standard pupillary
examination in predicting the outcome of post-CA coma, and
to compare its prognostic accuracy to that of electro-physio-
logical exams, including EEG and SSEP.
Methods
Patients
Subjects were part of an ongoing prospective outcome
database of comatose CA patients, successfully
resuscitated from an out-of-hospital CA and admitted to the
medical/surgical ICU of the Lausanne University Hospital,
Lausanne, Switzerland, over a 1-year period. Approval for
the study was given by the Ethical Committee of the
University of Lausanne. The population consisted of
patients older than 16 years admitted for coma following
out-of-hospital CA between June 2012 and June 2013,
treated with TH.
General Management
Patients were admitted to the ICU where TH was applied
following a standardized written institutional algorithm, as
recently described [20–22]. TH was considered in adults
with cardiac and non-cardiac etiologies of CA, regardless
of the initial CA rhythm, unless presenting severe hemo-
dynamic instability, or a patient’s ‘‘do not resuscitate’’
order [7, 23].
Cooling was induced immediately on hospital admission
with ice-cold packs and intravenous ice-cold fluids. Sub-
sequently, TH was maintained at 33 ± 1 C for 24 h using
a surface cooling device with a computerized adjustment of
patient temperature target (Arctic Sun 2200 TTM, Bard
Medical, Louisville, CO, USA). Sedation (midazolam,
0.1 mg/kg/h), analgesia (fentanyl, 1.5 lg/kg/h) and neu-
romuscular blocking agents (rocuronium 0.6 mg/kg bolus,
if shivering) were administered intravenously during TH,
according to a written standardized algorithm, and were
discontinued after passive rewarming, once core tempera-
ture was above 35 C.
Patients were mechanically ventilated to target PaCO2
between 35 and 45 mmHg and PaO2 of 80–100 mmHg.
Mean arterial pressure was maintained >70 mmHg with
volume resuscitation (mainly isotonic solutions) and nor-
epinephrine when needed.
Measure of Pupillary Reactivity
Measure of Standard Pupillary Light Reactivity
Standard pupillary light reactivity (PLR) was measured
manually using a standard pen light by the ICU nurse in
charge of the patient, according to our algorithm and
standard practices of care. Standard PLR was coded qual-
itatively as absent (no reactivity observed) or present when
reactivity was observed.
Measure of Quantitative Pupillary Light Reactivity
The NeuroLight Algiscan (IDMED, Marseille, France) is a
video automated pupillometer that allows the measure of
PLR quantitatively. This portable pupillometer device con-
tains an infrared camera that enables the video registration of
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the variation of the pupillary surface. It integrates a cali-
brated light stimulation (320 Lux, 1 s) that allows the rapid
and precise measurement (&0.05 mm limit) of patient PLR.
Baseline pupil size (expressed in mm) and the quantitative
PLR (expressed as the percentage of pupillary light
response) are measured within 4 s from the start of a cali-
brated light stimulation. Measure of quantitative PLR was
conducted by the ICU research nurse (TS) and was per-
formed in triplicates for each eye at two time points: at day 1
after CA, during TH and under sedation-analgesia and at day
2, after CA, following TH and rewarming, in normothermic
conditions, off sedation, and analgesia. At each time point,
the best value was retained for the analysis.
Electrophysiological Tests
Video-EEGs (Viasys Neurocare, Madison, WI, USA) were
performed at day 1, during TH, and at day 2, in normo-
thermia, using 21 electrodes according to the international
10–20 system. Background reactivity was tested at the
bedside, as previously reported, by applying repetitive
auditory, visual, and nociceptive stimuli [7, 23]. EEG
findings were categorized by certified EEG interpreters
according to the presence/absence of background reactiv-
ity, defined as an activity of C10 lV (regardless of
frequency) with any clear and reproducible change in
amplitude or frequency upon stimulation, excluding
‘‘stimulus induced rhythmic, periodic, or ictal discharges’’
(SIRPIDS) and muscle artifacts [7, 10].
The cortical N20 responses on SSEP, performed at day 2 in
normothermia and off sedation, were categorized as present or
bilaterally absent, defined as no clear negative deflection at
18–25 ms followed by a positive wave on both sides.
Study Design
The study was prospective and double-blinded, i.e., the neu-
rologists who performed electrophysiological tests and
assessed patient outcome were blinded to quantitative PLR, and
the research ICU nurse who performed the quantitative PLR
was blinded to standard PLR and electrophysiological tests.
Withdrawal of Life Support
The objective of this study was to evaluate the prognostic
value of automated pupillometry in comatose CA patients
and to compare it to that of standard tools that were utilized
routinely when assessing prognosis. According to our
practice, neurological examination and EEG were per-
formed at two time points, during TH and at about 48 h, as
described in our previous studies [7, 20, 23]. Additional
tests were performed at 48 and 72 h, including SSEP and
NSE. The decision to withdraw life support was based on a
multimodal approach that included all these tests, and the
final decision was taken following a consensus between
neurologists and intensivists in charge of the patient.
Withdrawal of life support was never done before 72 h, to
avoid premature withdrawal. Specifically, withdrawal of
life support was considered upon the occurrence of two or
more out of four criteria after more than 72 h after CA:
incomplete return of brainstem reflexes, treatment-resistant
myoclonus, non-reactive EEG background, bilateral
absence of N20 on SSEP. Importantly, the results of
automated quantitative pupillometry were not taken into
account for the decision of withdrawal of life support.
Data Collection and Outcome Assessment
Baseline demographic data included age, gender, initial arrest
rhythm (shockable = ventricular fibrillation vs. non shock-
able = asystole or pulseless electrical activity), and time to
return of spontaneous circulation (ROSC). Outcome was
assessed at 3 months by a semi-structured telephone interview
with the patient or the patient’s relatives using the Glasgow–
Pittsburgh Cerebral Performance Categories (CPC) [24].
Statistical Analysis
For the present study, the percentage of pupillary response
to a calibrated light stimulation measured with an auto-
mated infrared pupillometry was considered for the
analysis. Associations of quantitative PLR with 90-day
outcome (dichotomized as good = CPC 1–2, including
good recovery and moderate disability, vs. poor = CPC
3–5, including severe disability, vegetative state and death)
were analyzed using non-parametric Wilcoxon test.
Quantitative PLR values were then assessed for sensitivity
and specificity to identify the best cut-off value for the
prediction of 90-day poor outcome at both time points
studied, i.e., day 1 after CA during TH and sedation, and
day 2 after CA, following TH and rewarming, in normo-
thermia, off sedation. Prognostic variables (including:
presence/absence of standard PLR, performed simulta-
neously to quantitative PLR, at both time points; the best
value of quantitative PLR, expressed as the % pupillary
response, at both time points; presence/absence of EEG
background reactivity at day 2; presence/absence (bilater-
ally) of N20 on SSEP at day 2) were assessed for poor
outcome prediction using the area under the receiver
operating characteristic (ROC) curve. Multivariable logis-
tic regression was also performed to adjust outcome
prediction of quantitative PLR for known prognostic pre-
dictors (time from CA to ROSC and initial arrest rhythm).
The results of the logistic regression were expressed as the
odds ratio and 95 % confidence intervals of poor 90-day
outcome for each 10 % increase of pupillary response
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assessed with automated pupillometry. Comparisons
between the ROC curves were analyzed using v2 test. All
analyses were conducted using STATA 12 (STATA
Corporation, College Station, TX, USA). Statistical sig-
nificance was set at p < 0.05.
Results
Patient Characteristics
From June 2012 to June 2013, 50 consecutive comatose
patients (16 women and 34 men) resuscitated from out-of-
hospital CA were included in this study. All patients were
treated with TH and no patients were excluded. Patient
characteristics are summarized in Table 1. At 3 months, 23
(46 %) patients survived and had a good neurological
recovery (CPC 1–2) vs. 27 (54 %) patients who had a poor
outcome. Among patients with poor outcome, no subject
had a CPC 3 (severe disability) or 4 (vegetative state)
therefore all patients had a CPC 5 (death). Average time to
death was 5 days: all subjects died from withdrawal of life
support due to severe hypoxic-ischemic encephalopathy,
and all deaths occurred in-hospital (during the ICU stay for
the majority of patients).
Quantitative Pupillometry in Comatose Cardiac Arrest
Patients
Across all patients, quantitative PLR was lower at day 1,
during TH and sedation-analgesia [median 14 % (range
1–30 %)], than at day 2, in normothermia, off sedation-
analgesia [16 % (range 1–55 %), p = 0.005].
When looking at the two outcome groups, baseline pupil
size measured with the automated pupillometer did not
differ between patients with good outcome and those with
poor outcome, both during TH [on average 16 h from CA:
2.2 mm (range 1.4–4.3 mm) vs. 2.2 mm (range
1.7–5.3 mm), p = 0.53] and after passive rewarming in
normothermia [on average 46 h from CA: 2.3 mm (range
1.2–4.4 mm) vs. 2.2 mm (range 1.2–5.6 mm), p = 0.91].
Quantitative PLR was strongly associated with 3-month
outcome, when performed at the two time points (Table 2).
Quantitative PLR was first measured at day 1 during TH,
under sedation and analgesia: patients with good outcome
had a median quantitative PLR of 16 (9–23) % versus 10
(1–30) % in the poor outcome group (p = 0.0005). The
second test performed at day 2 after rewarming and off
sedation/analgesia was similarly highly predictive of out-
come: median quantitative PLR was 20 (13–39) % among
patients with good outcome versus 11 (1–55) % in the poor
outcome group (p = 0.0001). Figure 1 illustrates ranges of
individual % pupillary responses for the two outcome
groups at the two time points, at day 1, during TH (A) and
at day 2, after rewarming, at normothermia (B).
Of note, the total daily dose of sedatives (midazolam)
and vasopressors (norepinephrine) did not differ signifi-
cantly between the two outcome groups. The median
fentanyl dose differed significantly between the two out-
come groups, but was actually higher in patients with good
versus poor outcome (1.8 vs. 1.1 mg/day, p = 0.03;
Table 2). No patient received paralytics during the tests.
Quantitative Versus Standard Pupillary Reactivity
to Predict 90-Day Outcome
Using area under the ROC curve analysis, the best cut-off
value for quantitative PLR to predict 90-day poor outcome
was found <13 % (Fig. 2), at both time points, with an
area under the ROC curve 0.79 [95 % confidence intervals
(CI) 0.68–0.90] at day 1 during TH and 0.81 (95 % CI
0.72–0.91) at day 2.
A quantitative PLR < 13 % had significantly higher
accuracy to predict 90-day poor outcome than absence of
standard PLR, both at day 1 (area under the ROC curve
0.79 vs. 0.56, p = 0.005) and at day 2 (area under the ROC
curve 0.81 vs. 0.64, p = 0.006, Fig. 3).
Prognostic Accuracy of Quantitative PLR Versus EEG
and SSEP
At day 2, in normothermic conditions and off sedation-
analgesia, the ROC area of quantitative PLR < 13 % to
predict 90-day poor neurological outcome was 0.81 and did
not differ significantly from that of absent EEG reactivity
and bilaterally absent N20 on SSEP (tested on average
Table 1 Patient baseline demographics
Variable Value
Patients number 50
Age (years) 61 (31–88)
Gender, female/male 16/34
Time to ROSC (min) 20 (5–50)
Initial arrest rhythm
Shockable (ventricular fibrillation) 30
Non-shockable (asystole + pulseless electrical
activity)
20
(10 + 10)
Cerebral performance categories at 3 months
1. Good recovery 10
2. Moderate disability 13
3. Severe disability 0
4. Vegetative state 0
5. Death 27
Data are presented as median (minimum–maximum)
ROSC return of spontaneous circulation
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14 ± 11 h after rewarming: area under the ROC curve 0.81
for quantitative PLR < 13 % vs. 0.80 for absent EEG
reactivity and 0.73 for bilaterally absent SSEP, respectively,
both p > 0.20, v2 test), thereby suggesting comparable
prognostic accuracy of quantitative pupillometry when
compared to electro-physiological tests (Table 3).
Quantitative PLR is an Independent Predictor of 90-day
Outcome
Longer time to ROSC and an initial non-shockable CA
rhythm (asystole of pulseless electrical activity) were both
associated with poor neurological outcome (Table 2). After
adjustment for time to ROSC and initial CA rhythm, the
percentage pupillary response to a calibrated light stimu-
lation measured with automated pupillometry at day 2
remained a strong independent predictor of outcome: a
10 % increase of quantitative PLR was associated with a
71 % reduction in the risk of poor neurological recovery at
90 days (adjusted odds ratio 0.29, confidence intervals
0.10–0.84, p = 0.023, Table 4).
Discussion
The findings of our study can be summarized as follows:
(1) we show for the first time that quantitative pupillary
reactivity using automated infrared pupillometry was
Table 2 Univariate associations with 90-day neurological outcome
Variable Good outcome Poor outcome p
(CPC 1–2) (CPC 3–5)
Non-neurological variables
Age (years) 60 (34–81) 63 (31–88) 0.096
Time from CA to return of spontaneous circulation (min) 15 (5–30) 25 (5–50) <0.0001
Initial arrest non-shockable rhythm (nr/total nr) 4/23 16/27 0.0026
Total daily midazolam dose (mg) 161 (0–361.2) 125.6 (0–257.3) 0.11
Total daily fentanyl dose (lg) 1,775 (0–5,245) 1,072 (0–3,373) 0.033
Total daily dose norepinephrine (mg) 5.1 (0–44) 6.2 (0–177.7) 0.76
Neurological variables
Absent standard PLR at day 1 after CA (during TH) (nr/total nr) 5/23 9/27 0.36
Quantitative PLR at day 1 after CA (during TH) (%)* 16 (9–23) 10 (1–30) 0.0005
Absent standard PLR at day 2 after CA (nr/total nr) 1/23 9/27 0.01
Quantitative PLR at day 2 after CA (%)* 20 (13–39) 11 (1–55) 0.0001
Unreactive EEG background at day 2 after CA (nr/total nr) 0/23 15/25 <0.0001
Bilaterally absent N20 on SSEP at day 2 after CA (nr/total nr) 0/23 10/22 0.0002
Data are presented as median (ranges)
CA cardiac arrest, CPC cerebral performance categories, EEG electroencephalography, SSEP somato-sensory evoked potentials, TH therapeutic
hypothermia
* Quantitative pupillary light reactivity [PLR, expressed as the percentage response of pupillary reactivity to a calibrated light stimulus (320 Lux,
1 s)] was measured with an automated infrared pupillometry: the best value of triplicates performed on both eyes was retained for the analysis
Fig. 1 Individual percentage of pupillary light response in the good
outcome (CPC 1 and 2) and the poor outcome (CPC 3–5) group at day
1 (during therapeutic hypothermia and sedation, panel A) and at day 2
(after rewarming, at normothermia and off sedation, panel B). The
large line represents the median, the small lines the interquartile
ranges. CPC cerebral performance categories
304 Neurocrit Care (2014) 21:300–308
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superior to standard qualitative pupillary reactivity using a
manual pen light in predicting long-term neurological
recovery following post-CA coma, both during TH and
sedation and in normothermic conditions without sedation-
analgesia; (2) the percentage increase in pupillary reac-
tivity was a strong predictor of prognosis, independent of
the duration of CA and the initial arrest rhythm; (3) in our
single-center cohort, quantitative pupillary reactivity had
comparable prognostic performance than electro-physio-
logical exams, including EEG background reactivity and
SSEP.
Neurological Examination for the Prognostication
of Coma After CA
Before TH was considered a standard of care for the
treatment of patients with coma after CA, the absence of
motor response and the lack of pupillary and corneal
reflexes were considered strong predictors of poor out-
come, with a false-positive rate for poor prognosis close to
0 % at day 3 [4]. However, following the increasing uti-
lization of TH, several studies demonstrated that
neurological examination—although still remaining a key
step in the evaluation of prognosis—may be inaccurate,
partly because of the confounding effect of hypothermia
and sedation on neurological responses [5, 6]. This may
lead to premature false diagnoses of poor prognosis in
patients who may eventually awake, as recently shown by
Perman et al. [25] who found that among 28 patients with
early clinical signs of ‘‘poor’’ neurological prognosis, six
eventually survived to discharge with favorable neurologic
recovery. Standard PLR may be misleading [26, 27] and it
has been recommended to complement it by other prog-
nostic tools, such as EEG and SSEP [28]. Although of great
value, the disadvantage of all electrophysiological tests is
that they are not quantitative and require specific expertise
and substantial ICU implementation.
Quantitative Versus Standard Pupillary Light Response
Automated pupillometry has the advantage to be quanti-
tative, simple to use and therefore potentially widely
available and easy to implement in routine critical care
practice. Here we showed that quantitative PLR is superior
to standard PLR in predicting neurological outcome of
post-CA coma. Despite the % pupillary response to a cal-
ibrated light stimulus was lower during TH and sedation
than in normothermic conditions and off sedation/analge-
sia, the prognostic value of quantitative PLR was not
affected by sedation, analgesia, or the amount of vaso-
pressors. This reinforce the validity of automated
pupillometry in providing precise measurement of pupil
size and reactivity to light stimulation, irrespective of
temperature, sedation, and vasopressor conditions, already
at an early phase (within 48 h) following coma after CA.
Automated Pupillometry has Comparable Prognostic
Accuracy than Electro-physiological Exams
Because EEG and SSEP are part of standard care at our
center and are increasingly used to improve the accuracy of
coma prognostication after CA, we also analyzed whether
the prognostic accuracy of quantitative PLR was at least
comparable to that of electro-pysiological exams. By
comparing the area under the ROC curve to predict 90-day
outcome of the 3 tests, we found that indeed quantitative
PLR yielded comparable prognostic accuracy than EEG
reactivity and SSEP. As we previously said, electrophysi-
ological tests are of great value to improve prognostic
accuracy of coma after CA. However, EEG and SSEP are
Fig. 2 ROC curve analysis for
quantitative pupillary light
reactivity (PLR), defined as the
percentage pupillary response to
a calibrated light stimulus
(320 Lux, 1 s). A quantitative
PLR <13 % was the best cut-
off value to predict 90-day poor
neurological outcome
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not always available and require both a specific expertise
and substantial effort for ICU implementation.
In summary, our findings identify quantitative auto-
mated pupillometry as a new method of coma
prognostication, which seems unaffected by TH and drug
elimination, appears more accurate than standard pupillary
light response and seems to have comparable prognostic
performance than electro-physiological exams.
Our results are promising and prompt further larger
multicenter studies to confirm our findings and to evaluate
the value of quantitative pupillometry for the prognosti-
cation of post-CA coma. Awaiting such confirmatory
studies, prognostication of CA should rely on a multimodal
approach, including clinical examination, EEG, SSEP, and
serum biomarkers (such as neuron specific enolase) [15, 20,
29]. It is conceivable that quantitative pupillometry may in
the future be incorporated into such multimodal prognostic
approach and become a standard tool of coma
prognostication.
Study Limitations
The main limitation of this study is the sample size and the
fact that it was single-center therefore data may not be
generalized. However, data come from a homogeneous
Fig. 3 Areas under the ROC
curve for automated quantitative
pupillary light reactivity (PLR,
cut-off <13 %) and standard
PLR to predict 90-day poor
neurological outcome, at day 1
after cardiac arrest, during
therapeutic hypothermia and
sedation (panel A) and at day 2
after cardiac arrest, following
rewarming, in normothermia
and off sedation (panel B).
Quantitative PLR had better
prognostic performance than
standard PLR at day 1 (0.79 vs.
0.56, p = 0.005) and day 2
(0.81 vs. 0.64, p = 0.006)
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cohort of comatose patients with out-of-hospital CA treated
with TH, managed with a written standardized algorithm
for induced cooling, sedation-analgesia, post-resuscitation
care, neurological assessment and withdrawal of care, as
described in our recent studies [7, 20–23]. In addition,
robust statistical analysis was performed and comparisons
with standard electrophysiological tests were conducted,
which appear to reinforce the main findings of the study.
While automated pupillometry provides a calibrated light
stimulation, the standard pen light may give variable
amount of illumination. This is a study bias and a major
limitation, but on the other hand it reflects actual critical
care practice more adequately.
An important issue to discuss is the relatively early
prognostic assessment in our study. Automated pupillom-
etry was in fact performed at a relatively early stage
(within 48 h from CA), according to the standard algorithm
for the prognostication of coma after CA in use at our
institution. However, we wish to underline that the objec-
tive of our study was not to approximate brain death at an
early time point. Rather, the objective of the present
investigation was to evaluate the prognostic value of a new
tool for the quantitative measure of pupillary light response
using an automated pupillometry in comatose CA patients
and to compare it to that of standard pupil reactivity using a
pen light. In our practice, neurological examination is
performed in combination with EEG (performed at two
time points, at day 1, during TH, and at day 2, & 48 h
after CA) and SSEP, performed at day 2. The decision to
withdraw life support is based on a multimodal approach
that includes all these tests, and is taken after a consensus
between neurologists and intensivists in charge of the
patient, and never before 72 h [20]. All poor outcome
patients died, so further study will be required to determine
the accuracy of quantitative pupillometry to predict poor
neurological recovery or death more specifically. Given the
results of the recent targeted temperature management trial
[30], and the likely shift to move from induced hypother-
mia to controlled normothermia in the near future, our
results may need to be replicated under conditions of
normothermia instead of hypothermia treatment. Finally,
although the study was blinded for outcome assessments,
we cannot completely exclude that quantitative pupillom-
etry results may still have influenced treatment decisions
and the so-called self-fulfilling prophecy inherent to this
kind of study.
Table 3 Prognostic performance for 90-day neurological outcome of standard pupillary reactivity, quantitative pupillary reactivity, electro-
encephalography (EEG), and somato-sensory evoked potentials (SSEP), assessed using the area under the ROC curve analysis
Variable Sensitivity (%) Specificity (%) PPV (%) NPV (%) ROC area
Day 1 after cardiac arrest (during therapeutic hypothermia, under sedation-analgesia)
Quantitative PLR < 13 %* 66.7 (46–83.5) 91.3 (72–98.9) 90 (68.3–98.8) 70 (50.6–85.3) 0.79 (0.68–0.90)
Absent standard PLR 33.3 (16.5–54) 78.3 (56.3–92.5) 64.3 (35.1–87.2) 50 (32.9–67.1) 0.56 (0.43–0.68)
Day 2 after cardiac arrest (after rewarming, in normothermia, off sedation-analgesia)
Quantitative PLR < 13 %* 63 (42.4–80.6) 100 (85.2–100) 100 (80.5–100) 69.7 (51.3–84.4) 0.81 (0.72–0.91)
Absent standard PLR 33.3 (16.5–54) 95.7 (78.1–99.9) 90 (55.5–99.7) 55 (38.5–70.7) 0.64 (0.54–0.74)
Absent EEG reactivity 60 (38.7–78.9) 100 (85.2–100) 100 (78.2–100) 69.7 (51.3–84.4) 0.80 (0.70–0.90)
Bilaterally absent SSEP 45.5 (24.4–67.8) 100 (85.2–100) 100 (69.2–100) 65.7 (47.8–80.9) 0.73 (0.62–0.83)
Data are presented as values (95 % confidence intervals)
NPV negative predictive value, PPV positive predictive value
* Quantitative pupillary light reactivity [PLR, expressed as the percentage response of pupillary reactivity to a calibrated light stimulus (320 Lux,
1 s)] was measured with an automated infrared pupillometry. Standard PLR was measured with a manual pen light
Table 4 Multivariable logistic regression
Variable Adjusted odds ratio (95 %
confidence intervals)
of unfavorable outcome (CPC 3–5) at 90 days
z p value
10 % increase in quantitative PLR at 48 h after cardiac arrest 0.29 (0.10–0.82) -2.27 0.023
Time from CA to ROSC, min 1.28 (1.09–1.51) 3.03 0.002
Non-shockable rhythm 48.5 (3.35–702.03) 2.85 0.004
Quantitative pupillary light reactivity [PLR, expressed as the percentage response of pupillary reactivity to a calibrated light stimulus (320 Lux,
1 s)] was measured with an automated infrared pupillometry. For a 10 % increase of pupillary reactivity—measured by automated infrared
pupillometry at day 2 in normothermia—there was a 71 % reduction in the risk of poor neurological recovery at 90 days
CA cardiac arrest, CPC cerebral performance categories, ROSC return of spontaneous circulation
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Conclusions
Our single-center prospective cohort study shows that
automated quantitative pupillometry is superior to standard
pupillary examination in predicting poor 90-day outcome
after CA, irrespective of hypothermic conditions and seda-
tion and has comparable prognostic accuracy than
electrophysiological tests, including EEG and SSEP. Our
data suggest that quantitative pupillometry might be an
accurate and simple tool for the prognostication of post-CA
coma. Additional larger multicenter studies are warranted to
confirm the value of quantitative pupillometry in this setting.
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